Man Group’s Gossamer Bio GOSS Stock Holding History

Man Group’s Portfolio GOSS Stock Details GOSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-379,882	Closed	-$347K	–	2176
2023 Q4	$347K	Buy	+379,882	New	+$281K	﹤0.01%	1780
2023 Q3	–	Hold	0	–	–	–	1864

Other funds holding GOSS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Man Group's GOSS Position: Q1 2024 in Review

Man Group sold out of Gossamer Bio (GOSS) in Q1 2024, closing a stake of 379,882 shares — an estimated $347K sold.

Man Group first reported a position in GOSS in Q4 2023 and held it in 1 quarter. The position peaked at $347K in Q4 2023. 110 funds tracked by Wall St. Rank hold GOSS as of Q1 2024.

Man Group reported no remaining Gossamer Bio position as of Q1 2024 after selling out during the quarter.
Man Group sold 379,882 Gossamer Bio shares in Q1 2024, an estimated $347K.
Man Group first reported a position in Gossamer Bio in Q4 2023 and held it in 1 quarter.
Man Group's Gossamer Bio position peaked at $347K in Q4 2023.
110 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2024.

Based on Man Group's 13F filing for Q1 2024, filed 15 May 2024.